开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2180880, encodeId=493421808800e, content=要三次全膜吗难道？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d29e1999113, createdName=06140, createdTime=Fri Jan 12 00:46:38 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183261, encodeId=17fb21832619f, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：代谢 经验分享：有点难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e988335060, createdName=ms9000000914161339, createdTime=Mon Jan 22 19:55:01 CST 2024, time=2024-01-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2178122, encodeId=4c4621e81229a, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗氧化 经验分享：等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34929047927, createdName=ms9000001597706396, createdTime=Sat Dec 30 13:21:58 CST 2023, time=2023-12-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2157831, encodeId=c605215e8317e, content=偏重的研究方向：抗氧化和氧化剂 经验分享：投稿10天进入Under review,要求WB未裁剪膜，不是未裁剪图像, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Fri Sep 15 14:06:20 CST 2023, time=2023-09-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106052, encodeId=04342106052de, content=麻烦问一下，做了动物实验，编辑说Please provide ethical code，应该提供什么呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oLmMT86qKHJCvU9R9jbp02yzPic3Cax73ZPoWfHzicRriaDqIO0u8p8RmXc36anAe7M9dnCrgchcdXPj3s9dW30EQ/132, createdBy=4d6a5121925, createdName=ms7330898630740957, createdTime=Wed Dec 14 19:44:00 CST 2022, time=2022-12-14, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1224154, encodeId=f8181224154cd, content=想问一下大家这个杂志初审一般多久呀？过了5天了还是一直pending review... ...好紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220611/201e590875a54afc8adb28c544807441/2350cbb418674821beb1d15f4eaab2fd.jpg, createdBy=0cb96579643, createdName=ms9000001426312969, createdTime=Thu Jun 02 21:47:33 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222318, encodeId=8e581222318c4, content=真快，实验室投了一篇，5月2号投稿，5月20号小修，5月23号修回，5月24号接收！神刊呀！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59875648511, createdName=ms8000000802797021, createdTime=Wed May 25 14:31:57 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230630, encodeId=d2fe1230630d2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗氧化;细胞吸收 经验分享：已投，结果未出，需要WB 原始数据图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=638c8226799, createdName=ms1000002018667159, createdTime=Tue Jul 05 09:55:03 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099859, encodeId=9f99209985935, content=偏重的研究方向：活性氧代谢 经验分享：坐标中国医院，可能是我们医院不够格吧，第二天秒拒，没有任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Fri Nov 11 12:17:45 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101341, encodeId=e98d2101341ba, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：外审前有审核，要求提供带maker的全膜条带，至少3次重复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac645504928, createdName=ms5000001412254804, createdTime=Fri Nov 18 15:59:45 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2024-01-12 06140 来自北京

要三次全膜吗难道？？

105 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2180880, encodeId=493421808800e, content=要三次全膜吗难道？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d29e1999113, createdName=06140, createdTime=Fri Jan 12 00:46:38 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183261, encodeId=17fb21832619f, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：代谢 经验分享：有点难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e988335060, createdName=ms9000000914161339, createdTime=Mon Jan 22 19:55:01 CST 2024, time=2024-01-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2178122, encodeId=4c4621e81229a, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗氧化 经验分享：等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34929047927, createdName=ms9000001597706396, createdTime=Sat Dec 30 13:21:58 CST 2023, time=2023-12-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2157831, encodeId=c605215e8317e, content=偏重的研究方向：抗氧化和氧化剂 经验分享：投稿10天进入Under review,要求WB未裁剪膜，不是未裁剪图像, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Fri Sep 15 14:06:20 CST 2023, time=2023-09-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106052, encodeId=04342106052de, content=麻烦问一下，做了动物实验，编辑说Please provide ethical code，应该提供什么呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oLmMT86qKHJCvU9R9jbp02yzPic3Cax73ZPoWfHzicRriaDqIO0u8p8RmXc36anAe7M9dnCrgchcdXPj3s9dW30EQ/132, createdBy=4d6a5121925, createdName=ms7330898630740957, createdTime=Wed Dec 14 19:44:00 CST 2022, time=2022-12-14, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1224154, encodeId=f8181224154cd, content=想问一下大家这个杂志初审一般多久呀？过了5天了还是一直pending review... ...好紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220611/201e590875a54afc8adb28c544807441/2350cbb418674821beb1d15f4eaab2fd.jpg, createdBy=0cb96579643, createdName=ms9000001426312969, createdTime=Thu Jun 02 21:47:33 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222318, encodeId=8e581222318c4, content=真快，实验室投了一篇，5月2号投稿，5月20号小修，5月23号修回，5月24号接收！神刊呀！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59875648511, createdName=ms8000000802797021, createdTime=Wed May 25 14:31:57 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230630, encodeId=d2fe1230630d2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗氧化;细胞吸收 经验分享：已投，结果未出，需要WB 原始数据图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=638c8226799, createdName=ms1000002018667159, createdTime=Tue Jul 05 09:55:03 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099859, encodeId=9f99209985935, content=偏重的研究方向：活性氧代谢 经验分享：坐标中国医院，可能是我们医院不够格吧，第二天秒拒，没有任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Fri Nov 11 12:17:45 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101341, encodeId=e98d2101341ba, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：外审前有审核，要求提供带maker的全膜条带，至少3次重复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac645504928, createdName=ms5000001412254804, createdTime=Fri Nov 18 15:59:45 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2024-01-22 ms9000000914161339 来自甘肃省

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：代谢
经验分享：有点难

107 0

[GetPortalCommentsPageByObjectIdResponse(id=2180880, encodeId=493421808800e, content=要三次全膜吗难道？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d29e1999113, createdName=06140, createdTime=Fri Jan 12 00:46:38 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183261, encodeId=17fb21832619f, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：代谢 经验分享：有点难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e988335060, createdName=ms9000000914161339, createdTime=Mon Jan 22 19:55:01 CST 2024, time=2024-01-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2178122, encodeId=4c4621e81229a, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗氧化 经验分享：等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34929047927, createdName=ms9000001597706396, createdTime=Sat Dec 30 13:21:58 CST 2023, time=2023-12-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2157831, encodeId=c605215e8317e, content=偏重的研究方向：抗氧化和氧化剂 经验分享：投稿10天进入Under review,要求WB未裁剪膜，不是未裁剪图像, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Fri Sep 15 14:06:20 CST 2023, time=2023-09-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106052, encodeId=04342106052de, content=麻烦问一下，做了动物实验，编辑说Please provide ethical code，应该提供什么呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oLmMT86qKHJCvU9R9jbp02yzPic3Cax73ZPoWfHzicRriaDqIO0u8p8RmXc36anAe7M9dnCrgchcdXPj3s9dW30EQ/132, createdBy=4d6a5121925, createdName=ms7330898630740957, createdTime=Wed Dec 14 19:44:00 CST 2022, time=2022-12-14, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1224154, encodeId=f8181224154cd, content=想问一下大家这个杂志初审一般多久呀？过了5天了还是一直pending review... ...好紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220611/201e590875a54afc8adb28c544807441/2350cbb418674821beb1d15f4eaab2fd.jpg, createdBy=0cb96579643, createdName=ms9000001426312969, createdTime=Thu Jun 02 21:47:33 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222318, encodeId=8e581222318c4, content=真快，实验室投了一篇，5月2号投稿，5月20号小修，5月23号修回，5月24号接收！神刊呀！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59875648511, createdName=ms8000000802797021, createdTime=Wed May 25 14:31:57 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230630, encodeId=d2fe1230630d2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗氧化;细胞吸收 经验分享：已投，结果未出，需要WB 原始数据图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=638c8226799, createdName=ms1000002018667159, createdTime=Tue Jul 05 09:55:03 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099859, encodeId=9f99209985935, content=偏重的研究方向：活性氧代谢 经验分享：坐标中国医院，可能是我们医院不够格吧，第二天秒拒，没有任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Fri Nov 11 12:17:45 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101341, encodeId=e98d2101341ba, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：外审前有审核，要求提供带maker的全膜条带，至少3次重复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac645504928, createdName=ms5000001412254804, createdTime=Fri Nov 18 15:59:45 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2023-12-30 ms9000001597706396 来自上海

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：抗氧化
经验分享：等待

112 0

[GetPortalCommentsPageByObjectIdResponse(id=2180880, encodeId=493421808800e, content=要三次全膜吗难道？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d29e1999113, createdName=06140, createdTime=Fri Jan 12 00:46:38 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183261, encodeId=17fb21832619f, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：代谢 经验分享：有点难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e988335060, createdName=ms9000000914161339, createdTime=Mon Jan 22 19:55:01 CST 2024, time=2024-01-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2178122, encodeId=4c4621e81229a, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗氧化 经验分享：等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34929047927, createdName=ms9000001597706396, createdTime=Sat Dec 30 13:21:58 CST 2023, time=2023-12-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2157831, encodeId=c605215e8317e, content=偏重的研究方向：抗氧化和氧化剂 经验分享：投稿10天进入Under review,要求WB未裁剪膜，不是未裁剪图像, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Fri Sep 15 14:06:20 CST 2023, time=2023-09-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106052, encodeId=04342106052de, content=麻烦问一下，做了动物实验，编辑说Please provide ethical code，应该提供什么呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oLmMT86qKHJCvU9R9jbp02yzPic3Cax73ZPoWfHzicRriaDqIO0u8p8RmXc36anAe7M9dnCrgchcdXPj3s9dW30EQ/132, createdBy=4d6a5121925, createdName=ms7330898630740957, createdTime=Wed Dec 14 19:44:00 CST 2022, time=2022-12-14, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1224154, encodeId=f8181224154cd, content=想问一下大家这个杂志初审一般多久呀？过了5天了还是一直pending review... ...好紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220611/201e590875a54afc8adb28c544807441/2350cbb418674821beb1d15f4eaab2fd.jpg, createdBy=0cb96579643, createdName=ms9000001426312969, createdTime=Thu Jun 02 21:47:33 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222318, encodeId=8e581222318c4, content=真快，实验室投了一篇，5月2号投稿，5月20号小修，5月23号修回，5月24号接收！神刊呀！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59875648511, createdName=ms8000000802797021, createdTime=Wed May 25 14:31:57 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230630, encodeId=d2fe1230630d2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗氧化;细胞吸收 经验分享：已投，结果未出，需要WB 原始数据图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=638c8226799, createdName=ms1000002018667159, createdTime=Tue Jul 05 09:55:03 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099859, encodeId=9f99209985935, content=偏重的研究方向：活性氧代谢 经验分享：坐标中国医院，可能是我们医院不够格吧，第二天秒拒，没有任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Fri Nov 11 12:17:45 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101341, encodeId=e98d2101341ba, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：外审前有审核，要求提供带maker的全膜条带，至少3次重复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac645504928, createdName=ms5000001412254804, createdTime=Fri Nov 18 15:59:45 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2023-09-15 ms5000001127810224 来自浙江省

偏重的研究方向：抗氧化和氧化剂
经验分享：投稿10天进入Under review,要求WB未裁剪膜，不是未裁剪图像

127 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2180880, encodeId=493421808800e, content=要三次全膜吗难道？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d29e1999113, createdName=06140, createdTime=Fri Jan 12 00:46:38 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183261, encodeId=17fb21832619f, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：代谢 经验分享：有点难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e988335060, createdName=ms9000000914161339, createdTime=Mon Jan 22 19:55:01 CST 2024, time=2024-01-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2178122, encodeId=4c4621e81229a, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗氧化 经验分享：等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34929047927, createdName=ms9000001597706396, createdTime=Sat Dec 30 13:21:58 CST 2023, time=2023-12-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2157831, encodeId=c605215e8317e, content=偏重的研究方向：抗氧化和氧化剂 经验分享：投稿10天进入Under review,要求WB未裁剪膜，不是未裁剪图像, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Fri Sep 15 14:06:20 CST 2023, time=2023-09-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106052, encodeId=04342106052de, content=麻烦问一下，做了动物实验，编辑说Please provide ethical code，应该提供什么呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oLmMT86qKHJCvU9R9jbp02yzPic3Cax73ZPoWfHzicRriaDqIO0u8p8RmXc36anAe7M9dnCrgchcdXPj3s9dW30EQ/132, createdBy=4d6a5121925, createdName=ms7330898630740957, createdTime=Wed Dec 14 19:44:00 CST 2022, time=2022-12-14, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1224154, encodeId=f8181224154cd, content=想问一下大家这个杂志初审一般多久呀？过了5天了还是一直pending review... ...好紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220611/201e590875a54afc8adb28c544807441/2350cbb418674821beb1d15f4eaab2fd.jpg, createdBy=0cb96579643, createdName=ms9000001426312969, createdTime=Thu Jun 02 21:47:33 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222318, encodeId=8e581222318c4, content=真快，实验室投了一篇，5月2号投稿，5月20号小修，5月23号修回，5月24号接收！神刊呀！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59875648511, createdName=ms8000000802797021, createdTime=Wed May 25 14:31:57 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230630, encodeId=d2fe1230630d2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗氧化;细胞吸收 经验分享：已投，结果未出，需要WB 原始数据图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=638c8226799, createdName=ms1000002018667159, createdTime=Tue Jul 05 09:55:03 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099859, encodeId=9f99209985935, content=偏重的研究方向：活性氧代谢 经验分享：坐标中国医院，可能是我们医院不够格吧，第二天秒拒，没有任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Fri Nov 11 12:17:45 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101341, encodeId=e98d2101341ba, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：外审前有审核，要求提供带maker的全膜条带，至少3次重复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac645504928, createdName=ms5000001412254804, createdTime=Fri Nov 18 15:59:45 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2022-12-14 ms7330898630740957 来自甘肃省

麻烦问一下，做了动物实验，编辑说Please provide ethical code，应该提供什么呀？

131 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2180880, encodeId=493421808800e, content=要三次全膜吗难道？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d29e1999113, createdName=06140, createdTime=Fri Jan 12 00:46:38 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183261, encodeId=17fb21832619f, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：代谢 经验分享：有点难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e988335060, createdName=ms9000000914161339, createdTime=Mon Jan 22 19:55:01 CST 2024, time=2024-01-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2178122, encodeId=4c4621e81229a, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗氧化 经验分享：等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34929047927, createdName=ms9000001597706396, createdTime=Sat Dec 30 13:21:58 CST 2023, time=2023-12-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2157831, encodeId=c605215e8317e, content=偏重的研究方向：抗氧化和氧化剂 经验分享：投稿10天进入Under review,要求WB未裁剪膜，不是未裁剪图像, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Fri Sep 15 14:06:20 CST 2023, time=2023-09-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106052, encodeId=04342106052de, content=麻烦问一下，做了动物实验，编辑说Please provide ethical code，应该提供什么呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oLmMT86qKHJCvU9R9jbp02yzPic3Cax73ZPoWfHzicRriaDqIO0u8p8RmXc36anAe7M9dnCrgchcdXPj3s9dW30EQ/132, createdBy=4d6a5121925, createdName=ms7330898630740957, createdTime=Wed Dec 14 19:44:00 CST 2022, time=2022-12-14, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1224154, encodeId=f8181224154cd, content=想问一下大家这个杂志初审一般多久呀？过了5天了还是一直pending review... ...好紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220611/201e590875a54afc8adb28c544807441/2350cbb418674821beb1d15f4eaab2fd.jpg, createdBy=0cb96579643, createdName=ms9000001426312969, createdTime=Thu Jun 02 21:47:33 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222318, encodeId=8e581222318c4, content=真快，实验室投了一篇，5月2号投稿，5月20号小修，5月23号修回，5月24号接收！神刊呀！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59875648511, createdName=ms8000000802797021, createdTime=Wed May 25 14:31:57 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230630, encodeId=d2fe1230630d2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗氧化;细胞吸收 经验分享：已投，结果未出，需要WB 原始数据图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=638c8226799, createdName=ms1000002018667159, createdTime=Tue Jul 05 09:55:03 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099859, encodeId=9f99209985935, content=偏重的研究方向：活性氧代谢 经验分享：坐标中国医院，可能是我们医院不够格吧，第二天秒拒，没有任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Fri Nov 11 12:17:45 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101341, encodeId=e98d2101341ba, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：外审前有审核，要求提供带maker的全膜条带，至少3次重复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac645504928, createdName=ms5000001412254804, createdTime=Fri Nov 18 15:59:45 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2022-06-02 ms9000001426312969

想问一下大家这个杂志初审一般多久呀？过了5天了还是一直pending review... ...好紧张

172 19

展开19条回复

[GetPortalCommentsPageByObjectIdResponse(id=2180880, encodeId=493421808800e, content=要三次全膜吗难道？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d29e1999113, createdName=06140, createdTime=Fri Jan 12 00:46:38 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183261, encodeId=17fb21832619f, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：代谢 经验分享：有点难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e988335060, createdName=ms9000000914161339, createdTime=Mon Jan 22 19:55:01 CST 2024, time=2024-01-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2178122, encodeId=4c4621e81229a, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗氧化 经验分享：等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34929047927, createdName=ms9000001597706396, createdTime=Sat Dec 30 13:21:58 CST 2023, time=2023-12-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2157831, encodeId=c605215e8317e, content=偏重的研究方向：抗氧化和氧化剂 经验分享：投稿10天进入Under review,要求WB未裁剪膜，不是未裁剪图像, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Fri Sep 15 14:06:20 CST 2023, time=2023-09-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106052, encodeId=04342106052de, content=麻烦问一下，做了动物实验，编辑说Please provide ethical code，应该提供什么呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oLmMT86qKHJCvU9R9jbp02yzPic3Cax73ZPoWfHzicRriaDqIO0u8p8RmXc36anAe7M9dnCrgchcdXPj3s9dW30EQ/132, createdBy=4d6a5121925, createdName=ms7330898630740957, createdTime=Wed Dec 14 19:44:00 CST 2022, time=2022-12-14, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1224154, encodeId=f8181224154cd, content=想问一下大家这个杂志初审一般多久呀？过了5天了还是一直pending review... ...好紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220611/201e590875a54afc8adb28c544807441/2350cbb418674821beb1d15f4eaab2fd.jpg, createdBy=0cb96579643, createdName=ms9000001426312969, createdTime=Thu Jun 02 21:47:33 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222318, encodeId=8e581222318c4, content=真快，实验室投了一篇，5月2号投稿，5月20号小修，5月23号修回，5月24号接收！神刊呀！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59875648511, createdName=ms8000000802797021, createdTime=Wed May 25 14:31:57 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230630, encodeId=d2fe1230630d2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗氧化;细胞吸收 经验分享：已投，结果未出，需要WB 原始数据图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=638c8226799, createdName=ms1000002018667159, createdTime=Tue Jul 05 09:55:03 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099859, encodeId=9f99209985935, content=偏重的研究方向：活性氧代谢 经验分享：坐标中国医院，可能是我们医院不够格吧，第二天秒拒，没有任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Fri Nov 11 12:17:45 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101341, encodeId=e98d2101341ba, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：外审前有审核，要求提供带maker的全膜条带，至少3次重复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac645504928, createdName=ms5000001412254804, createdTime=Fri Nov 18 15:59:45 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2022-05-25 ms8000000802797021

真快，实验室投了一篇，5月2号投稿，5月20号小修，5月23号修回，5月24号接收！神刊呀！

204 14

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=2180880, encodeId=493421808800e, content=要三次全膜吗难道？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d29e1999113, createdName=06140, createdTime=Fri Jan 12 00:46:38 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183261, encodeId=17fb21832619f, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：代谢 经验分享：有点难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e988335060, createdName=ms9000000914161339, createdTime=Mon Jan 22 19:55:01 CST 2024, time=2024-01-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2178122, encodeId=4c4621e81229a, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗氧化 经验分享：等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34929047927, createdName=ms9000001597706396, createdTime=Sat Dec 30 13:21:58 CST 2023, time=2023-12-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2157831, encodeId=c605215e8317e, content=偏重的研究方向：抗氧化和氧化剂 经验分享：投稿10天进入Under review,要求WB未裁剪膜，不是未裁剪图像, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Fri Sep 15 14:06:20 CST 2023, time=2023-09-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106052, encodeId=04342106052de, content=麻烦问一下，做了动物实验，编辑说Please provide ethical code，应该提供什么呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oLmMT86qKHJCvU9R9jbp02yzPic3Cax73ZPoWfHzicRriaDqIO0u8p8RmXc36anAe7M9dnCrgchcdXPj3s9dW30EQ/132, createdBy=4d6a5121925, createdName=ms7330898630740957, createdTime=Wed Dec 14 19:44:00 CST 2022, time=2022-12-14, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1224154, encodeId=f8181224154cd, content=想问一下大家这个杂志初审一般多久呀？过了5天了还是一直pending review... ...好紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220611/201e590875a54afc8adb28c544807441/2350cbb418674821beb1d15f4eaab2fd.jpg, createdBy=0cb96579643, createdName=ms9000001426312969, createdTime=Thu Jun 02 21:47:33 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222318, encodeId=8e581222318c4, content=真快，实验室投了一篇，5月2号投稿，5月20号小修，5月23号修回，5月24号接收！神刊呀！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59875648511, createdName=ms8000000802797021, createdTime=Wed May 25 14:31:57 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230630, encodeId=d2fe1230630d2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗氧化;细胞吸收 经验分享：已投，结果未出，需要WB 原始数据图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=638c8226799, createdName=ms1000002018667159, createdTime=Tue Jul 05 09:55:03 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099859, encodeId=9f99209985935, content=偏重的研究方向：活性氧代谢 经验分享：坐标中国医院，可能是我们医院不够格吧，第二天秒拒，没有任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Fri Nov 11 12:17:45 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101341, encodeId=e98d2101341ba, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：外审前有审核，要求提供带maker的全膜条带，至少3次重复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac645504928, createdName=ms5000001412254804, createdTime=Fri Nov 18 15:59:45 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2022-07-05 ms1000002018667159

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：抗氧化;细胞吸收
经验分享：已投，结果未出，需要WB 原始数据图片

153 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2180880, encodeId=493421808800e, content=要三次全膜吗难道？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d29e1999113, createdName=06140, createdTime=Fri Jan 12 00:46:38 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183261, encodeId=17fb21832619f, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：代谢 经验分享：有点难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e988335060, createdName=ms9000000914161339, createdTime=Mon Jan 22 19:55:01 CST 2024, time=2024-01-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2178122, encodeId=4c4621e81229a, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗氧化 经验分享：等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34929047927, createdName=ms9000001597706396, createdTime=Sat Dec 30 13:21:58 CST 2023, time=2023-12-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2157831, encodeId=c605215e8317e, content=偏重的研究方向：抗氧化和氧化剂 经验分享：投稿10天进入Under review,要求WB未裁剪膜，不是未裁剪图像, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Fri Sep 15 14:06:20 CST 2023, time=2023-09-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106052, encodeId=04342106052de, content=麻烦问一下，做了动物实验，编辑说Please provide ethical code，应该提供什么呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oLmMT86qKHJCvU9R9jbp02yzPic3Cax73ZPoWfHzicRriaDqIO0u8p8RmXc36anAe7M9dnCrgchcdXPj3s9dW30EQ/132, createdBy=4d6a5121925, createdName=ms7330898630740957, createdTime=Wed Dec 14 19:44:00 CST 2022, time=2022-12-14, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1224154, encodeId=f8181224154cd, content=想问一下大家这个杂志初审一般多久呀？过了5天了还是一直pending review... ...好紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220611/201e590875a54afc8adb28c544807441/2350cbb418674821beb1d15f4eaab2fd.jpg, createdBy=0cb96579643, createdName=ms9000001426312969, createdTime=Thu Jun 02 21:47:33 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222318, encodeId=8e581222318c4, content=真快，实验室投了一篇，5月2号投稿，5月20号小修，5月23号修回，5月24号接收！神刊呀！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59875648511, createdName=ms8000000802797021, createdTime=Wed May 25 14:31:57 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230630, encodeId=d2fe1230630d2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗氧化;细胞吸收 经验分享：已投，结果未出，需要WB 原始数据图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=638c8226799, createdName=ms1000002018667159, createdTime=Tue Jul 05 09:55:03 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099859, encodeId=9f99209985935, content=偏重的研究方向：活性氧代谢 经验分享：坐标中国医院，可能是我们医院不够格吧，第二天秒拒，没有任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Fri Nov 11 12:17:45 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101341, encodeId=e98d2101341ba, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：外审前有审核，要求提供带maker的全膜条带，至少3次重复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac645504928, createdName=ms5000001412254804, createdTime=Fri Nov 18 15:59:45 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2022-11-11 ms8000000700114189

偏重的研究方向：活性氧代谢
经验分享：坐标中国医院，可能是我们医院不够格吧，第二天秒拒，没有任何理由

136 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2180880, encodeId=493421808800e, content=要三次全膜吗难道？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d29e1999113, createdName=06140, createdTime=Fri Jan 12 00:46:38 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183261, encodeId=17fb21832619f, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：代谢 经验分享：有点难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e988335060, createdName=ms9000000914161339, createdTime=Mon Jan 22 19:55:01 CST 2024, time=2024-01-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2178122, encodeId=4c4621e81229a, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗氧化 经验分享：等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34929047927, createdName=ms9000001597706396, createdTime=Sat Dec 30 13:21:58 CST 2023, time=2023-12-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2157831, encodeId=c605215e8317e, content=偏重的研究方向：抗氧化和氧化剂 经验分享：投稿10天进入Under review,要求WB未裁剪膜，不是未裁剪图像, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Fri Sep 15 14:06:20 CST 2023, time=2023-09-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106052, encodeId=04342106052de, content=麻烦问一下，做了动物实验，编辑说Please provide ethical code，应该提供什么呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/oLmMT86qKHJCvU9R9jbp02yzPic3Cax73ZPoWfHzicRriaDqIO0u8p8RmXc36anAe7M9dnCrgchcdXPj3s9dW30EQ/132, createdBy=4d6a5121925, createdName=ms7330898630740957, createdTime=Wed Dec 14 19:44:00 CST 2022, time=2022-12-14, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1224154, encodeId=f8181224154cd, content=想问一下大家这个杂志初审一般多久呀？过了5天了还是一直pending review... ...好紧张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220611/201e590875a54afc8adb28c544807441/2350cbb418674821beb1d15f4eaab2fd.jpg, createdBy=0cb96579643, createdName=ms9000001426312969, createdTime=Thu Jun 02 21:47:33 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222318, encodeId=8e581222318c4, content=真快，实验室投了一篇，5月2号投稿，5月20号小修，5月23号修回，5月24号接收！神刊呀！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59875648511, createdName=ms8000000802797021, createdTime=Wed May 25 14:31:57 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230630, encodeId=d2fe1230630d2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抗氧化;细胞吸收 经验分享：已投，结果未出，需要WB 原始数据图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=638c8226799, createdName=ms1000002018667159, createdTime=Tue Jul 05 09:55:03 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099859, encodeId=9f99209985935, content=偏重的研究方向：活性氧代谢 经验分享：坐标中国医院，可能是我们医院不够格吧，第二天秒拒，没有任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Fri Nov 11 12:17:45 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101341, encodeId=e98d2101341ba, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：外审前有审核，要求提供带maker的全膜条带，至少3次重复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac645504928, createdName=ms5000001412254804, createdTime=Fri Nov 18 15:59:45 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2022-11-18 ms5000001412254804

审稿速度:3.0 | 投稿命中率:50.0
经验分享：外审前有审核，要求提供带maker的全膜条带，至少3次重复

135 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务